Buy this Article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MS, RN

Abstract

* The Food and Drug Administration is requiring manufacturers of metformin and metformin-containing drugs to revise their labeling to indicate that metformin may be safely used in some patients with mild-to-moderate renal dysfunction.

 

* Nurses should regularly assess patients' estimated glomerular filtration rate to confirm that renal function remains adequate to support metformin therapy.